Related content

Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients

By Venkataraman V.   Wheless J.W.  

Epilepsy Research, Vol. 35, Iss. 2, 1999-06 ,pp. : 147-153

Elsevier

Access to resources Recommend Favorite

Oral/intravenous maintenance dosing of valproate following intravenous loading: a simulation

By Dutta S.   Cloyd J.C.   Granneman G.R.   Collins S.D.  

Epilepsy Research, Vol. 53, Iss. 1, 2003-02 ,pp. : 29-38

Elsevier

Access to resources Recommend Favorite

Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy

By Gidal B.E.   Anderson G.D.   Rutecki P.R.   Shaw R.   Lanning A.  

Epilepsy Research, Vol. 42, Iss. 1, 2000-11 ,pp. : 23-31

Elsevier

Access to resources Recommend Favorite

Valproate unbound fraction and distribution volume following rapid infusions in patients with epilepsy

By Cloyd J.C.   Dutta S.   Cao G.   Walch J.K.   Collins S.D.   Granneman G.R.   The Depacon Study Group  

Epilepsy Research, Vol. 53, Iss. 1, 2003-02 ,pp. : 19-27

Elsevier

Access to resources Recommend Favorite

Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy

By Kaminow L.   Schimschock J.R.   Hammer A.E.   Vuong A.  

Epilepsy & Behavior, Vol. 4, Iss. 6, 2003-12 ,pp. : 659-666

Elsevier

Access to resources Recommend Favorite